|1.||Wang, Xinru: 3 articles (09/2014 - 11/2011)|
|2.||Lu, Chuncheng: 3 articles (09/2014 - 11/2011)|
|3.||Xu, Miaofei: 3 articles (09/2014 - 11/2011)|
|4.||Xia, Yankai: 3 articles (09/2014 - 11/2011)|
|5.||Qin, Yufeng: 3 articles (09/2014 - 11/2011)|
|6.||Kim, Dong Wook: 3 articles (08/2011 - 07/2009)|
|7.||Sohn, Myung-Hee: 3 articles (08/2011 - 07/2009)|
|8.||Lim, Seok Tae: 3 articles (08/2011 - 07/2009)|
|9.||Kim, Eun-Mi: 3 articles (08/2011 - 07/2009)|
|10.||Jeong, Hwan-Jeong: 3 articles (08/2011 - 07/2009)|
11/01/2015 - "In this study, we reported that the transcriptional factor c-Myc functions as a downstream effector to dictate the therapeutic response to c-Met inhibitors in c-Met-addicted cancer and derived resistance. "
09/25/2014 - "Discovery of (S)-1-(1-(Imidazo[1,2-a]pyridin-6-yl)ethyl)-6-(1-methyl-1H-pyrazol-4-yl)-1H-[1,2,3]triazolo[4,5-b]pyrazine (volitinib) as a highly potent and selective mesenchymal-epithelial transition factor (c-Met) inhibitor in clinical development for treatment of cancer."
07/01/2012 - "Mesenchymal epithelial transition factor (c-Met) is an attractive target for cancer therapy. "
05/01/2011 - "Age, gender, tumor laterality, histology, lobe location of the tumor, c-T factor, pathological (p-) T factor, c-N factor, MN2, HM and skip N2 condition were used as prognostic variables. "
01/28/2003 - "Moreover, growth factor/c-erbB signaling is crucial for ovarian tumor growth/chemosensitivity. "
03/01/2011 - "In the current study, we set out to identify deletions in the azoospermia factor c (AZFc) region caused by NHR between palindromes. "
01/01/2015 - "The male fertility impairment depends on Y chromosome azoospermia factor c (AZFc) subdeletions, which varies highly in different geographical populations and in an Indian admixed population the frequency and effect of deletion on fertility is relatively poorly documented. "
09/01/2014 - "The azoospermia factor c (AZFc) region in the long arm of human Y chromosome is characterized by massive palindromes. "
01/01/2014 - "The azoospermia factor c (AZFc) region of the Y chromosome consists of repetitive amplicons and is therefore highly susceptible to structural rearrangements, such as deletions and duplications. "
09/01/2013 - "The AZFc(azoospermia factor c)/DAZ (deleted in azoospermia) duplications might underlie the susceptibility of Y-hg K* to spermatogenic impairment. "
07/01/2012 - "In recent studies, partial deletions of the azoospermia factor c region (AZFc) on the Y-chromosome have been detected in males with infertility problems. "
03/01/2013 - "The purpose of this study was to assess the relationship between chronically impaired spermatogenesis induced by exposing mice to doxorubicin (DXR) and expression of the infertility factor c-kit. "
|4.||Male Infertility (Male Sterility)
06/01/2010 - "[Study on the relationship between partial deletions in the azzospermia factor C region of Y chromosome and male infertility]."
01/01/2006 - "A recurrent partial azoospermia factor C (AZFc) deletion, called gr/gr, has been reported to be a male infertility risk factor. "
06/01/2002 - "The DAZ (deleted in azoospermia) gene family on the Y chromosome long arm is the major candidate for the AZFc (azoospermia factor c) phenotype of male infertility and it is expressed only in germ cells. "
01/01/2002 - "The deleted-in-azoospermia (DAZ) gene family constitutes the major candidate for the AZFc (azoospermia factor c) phenotype of male infertility, being deleted in about 10% of azoospermic and severely oligozoospermic subjects. "
02/01/2001 - "The DAZ (deleted in azoospermia) gene family is considered the major AZFc ("azoospermia factor" c) candidate responsible for male infertility. "
01/01/1992 - "We investigate the linkage between the transcriptional factor, c-fos, and expression of proenkephalin in rat C6 glioma cells. "
07/01/2009 - "Mesenchymal-epithelial transition factor (c-Met) is a receptor tyrosine kinase that has been shown to be overexpressed and mutated in a variety of malignancies, such as glioma. "
08/01/2011 - "In our previous study, mesenchymal-epithelial transition factor (c-Met)-binding peptides (cMBP) had been readily radiolabeled with radioactive iodide for glioma imaging because of five histidine amino acids. "
|2.||Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)
|3.||Vascular Endothelial Growth Factor C
|4.||Complement Factor B (Factor B)
|6.||Cyclooxygenase 2 (Cyclooxygenase-2)
|7.||Epidermal Growth Factor Receptor (EGF Receptor)
|8.||Complement Factor D (Factor D)
|10.||Somatomedin Receptors (Somatomedin Receptor)
|1.||Transplantation (Transplant Recipients)